OBIO insider buying

3 cluster buys

Orchestra BioMed Holdings, Inc. · Healthcare

When two or more insiders at Orchestra BioMed Holdings, Inc. buy OBIO on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in OBIO plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
3
Distinct insiders
9
Total bought
$2.5M
Market cap
$244.3M

Detected clusters

  • Aug 1 – Nov 14, 2025
    Detected Nov 14, 2025
    High conviction6 insiders
    Total bought
    $2.0M
    Market cap
    $244.3M
  • Apr 29 – Apr 30, 2025
    Detected Apr 30, 2025
    2 insiders
    Total bought
    $275.7K
    Market cap
    $257.5M
  • May 30 – Dec 23, 2024
    Detected Dec 23, 2024
    High conviction3 insiders
    Total bought
    $145.5K
    Market cap
    $244.3M

All notable open-market buys in OBIO

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Mar 13, 2026
Director, See Remarks
10,000$4.29$42.9KSEC ↗
Nov 14, 2025
Director, See Remarks
5,000$4.07$20.4KSEC ↗
Sep 19, 2025
Director
1,000$2.45$2.5KSEC ↗
Aug 25, 2025
Director
5,760$2.61$15.0KSEC ↗
Aug 25, 2025
Director, See Remarks
3,000$2.62$7.9KSEC ↗
Aug 25, 2025
Chief Financial Officer
2,000$2.55$5.1KSEC ↗
Aug 21, 2025
Director, See Remarks
6,000$2.49$14.9KSEC ↗
Aug 4, 2025
Director, See Remarks
20,000$2.75$55.0KSEC ↗
Aug 1, 2025
10% Owner
700,000$2.75$1.9MSEC ↗
Apr 30, 2025
10% Owner
49,900$2.99$149.2KSEC ↗
Apr 29, 2025
10% Owner
50,000$2.53$126.5KSEC ↗
Dec 23, 2024
Director, See Remarks
4,000$4.66$18.6KSEC ↗
Dec 19, 2024
Chief Financial Officer
1,000$4.83$4.8KSEC ↗
Dec 18, 2024
Director, See Remarks
5,000$4.91$24.6KSEC ↗
Sep 25, 2024
Director, See Remarks
2,000$4.74$9.5KSEC ↗
Sep 25, 2024
Director, See Remarks
2,000$4.73$9.5KSEC ↗
Sep 25, 2024
Director, See Remarks
2,000$4.70$9.4KSEC ↗
Sep 25, 2024
Director, See Remarks
1,500$4.86$7.3KSEC ↗
Sep 24, 2024
Director, See Remarks
2,500$4.91$12.3KSEC ↗
Aug 14, 2024
Director, See Remarks
2,500$5.84$14.6KSEC ↗
Jun 25, 2024
Director, See Remarks
1,000$6.95$7.0KSEC ↗
May 30, 2024
See Remarks
4,000$7.00$28.0KSEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

OBIO insider buying — FAQ

Are insiders buying OBIO stock?
Yes — 9 distinct insiders have bought OBIO (Orchestra BioMed Holdings, Inc.) on the open market, including 3 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Mar 16, 2026.
How much OBIO stock have insiders bought?
Insiders have bought a combined $2.5M of OBIO across 22 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in OBIO?
A cluster buy is two or more distinct Orchestra BioMed Holdings, Inc. insiders — officers, directors, or 10% owners — each buying OBIO on the open market within a rolling window. OBIO has 3 detected cluster buys to date.
Where does this OBIO insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in OBIO

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy OBIO within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding OBIO.